skip to content

Adaptive Brain Lab

 
4-year PhD studentship opportunity in collaboration with AstraZeneca “Multimodal AI-guided tools for early prediction of disease progression in neurodegenerative disorders” .  The project focuses on the development and implementation of AI-guided approaches for early prediction of neurodegenerative disorders.  This is a collaborative project between the Adaptive Brain Lab and AstraZeneca’s Neuroscience and Data Science & AI teams.  For more details, and to apply, please follow this link:
Astra Zeneca funded Non clinical PhD Studentship (Fixed Term) in 'Multimodal AI-guided tools for early prediction of disease progression in neurodegenerative disorders' - Job Opportunities - University of Cambridge
Application deadline is Feb 18th, 2024.
 

 

Twitter Feed

Latest news

Newly Published Paper

9 September 2024

New multimodal brain imaging study reveals a recurrent inhibitory plasticity mechanism that enhances sensory representations and optimises perceptual decisions. Jia K, Wang M, Steinwurzel C, Ziminski JJ, Xi Y, Emir U, Kourtzi Z. Recurrent inhibition refines mental templates to optimize perceptual decisions. Sci Adv. 2024...

Can AI help detect dementia early and accelerate drug discovery?

15 July 2024

Our cross-disciplinary team has developed new tools that predict dementia more precisely than the standard of care https://www.cam.ac.uk/research/news/artificial-intelligence-outperforms-clinical-tests-at-predicting-progress-of-alzheimers-disease https://youtu.be/FnDsNw57kuA A digital marker powered by AI detects dementia...

Newly Published Review Paper

21 June 2024

New review paper by @CambridgeABL on opportunities and challenges of training cognitive flexibility in real-world settings https://doi.org/10.1016/j.cobeha.2024.101413 @CambPsych @CamNeuro @CamBrainCNS